Delivery Order SPE2DB22D9309-SPE2DB25FAF07
Award Date
6/6/25
Potential Completion Date
6/30/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,691.16, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies. The contract has a completion date of May 9, 2025. DMS Pharmaceutical Group Inc. is a critical supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies, with a ceiling value of $1,691.16 and a performance period through May 30, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,634.04, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 18, 2024. The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, which is a pharmaceutical product. DMS Pharmaceutical Group Inc. has an Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $8,455.80 and an ultimate completion date of February 14, 2025. The contract provides for the delivery of a specialized pharmaceutical product, VISIONBLUE 0.06% SYRINGE 0.5ML, to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS...
This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, a specialized pharmaceutical product, with a ceiling value of $1,691.16. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This contract award is a delivery order (SPE2DB25FZG04) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,691.16 firm fixed-price contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies to support the medical needs of U.S. military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $3,268.08 award is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,556.54, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 15, 2023 and was awarded on November 24, 2023. DMS Pharmaceutical Group Inc. is the prime contractor for this award. The company specializes...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...